Dr. Essam Hamza reports

ROCKET DOCTOR AI ANNOUNCES STRONG Q3 2026 PATIENT VISIT GROWTH AND EXPECTS RECORD QUARTERLY REVENUE

Rocket Doctor AI Inc. had strong patient visit growth for the quarter ended Sept. 30, 2026, and expects to report record quarterly revenue for Q3 (third quarter) 2026.

The company completed 53,348 patient visits across its United States and Canadian operations during the third quarter. U.S. visits rose 56 per cent from the prior quarter (Q2 (second quarter) 2026), while Canadian visits increased 24 per cent from the same quarter last year. The results follow the company's Sept. 14, 2026, operational update, with final quarterly U.S. visit volumes exceeding the preliminary indicators previously communicated.

"Our Q3 performance highlights the accelerating demand for Rocket Doctor AI's physician-built, AI-powered platform across North America," said Dr. Essam Hamza, chief executive officer of Rocket Doctor AI. "Surpassing 50,000 total patient visits across Canada and the U.S. in a single quarter is a remarkable operational milestone. The 56-per-cent quarter-over-quarter growth in completed U.S. visits demonstrates the successful rollout of our multipayer strategy and expanding in-network coverage. As we continue to scale our footprint and strengthen payor relationships, we are laying a strong foundation for sustainable, long-term revenue growth.

"While U.S. patient volumes grew significantly in Q2, the associated revenue growth was not immediately reflected in our reported results because of the lag between patient visits, claims processing and cash collections. With U.S. patient visits increasing a further 56 per cent in Q3, we expect to begin seeing the financial benefits of that growth as collections catch up with clinical activity. Our expectation of record Q3 revenue is an encouraging indication of that progression."

The increase in completed U.S. visits and the number of U.S. clinical hours are important leading indicators to demonstrate the growth of Rocket Doctor AI's operational and financial performance. As a result, the company expects to report record quarterly revenue for Q3 2026.

Q3 2026 operational highlights:

• U.S. patient visits: 6,101 completed visits, an increase of 56 per cent from 3,911 in Q2 2026;
• U.S. clinical hours: 2,634 hours, an increase of 33 per cent from 1,987.5 in Q2 2026;
• Canadian patient visits: 47,247 completed visits, an increase of 24 per cent from 37,960 in Q3 2025.

The increase in U.S. visits reflects the company's continued execution of its multipayer strategy across key state markets. By continuing to build upon its network of over 20 in-network payer agreements spanning commercial, Medicare Advantage and Medicaid verticals, the company is driving scalable, quarter-over-quarter operational growth while laying a durable foundation to expand health care access and long-term revenue visibility.

Revenue recognition and timing lag

As detailed in the company's news release dated Sept. 1, 2026, it should be noted that because the company currently recognizes certain U.S. revenues on a cash basis, there is a timing lag between the significant increase in-patient visits and the corresponding recognition of revenue.

Further, as described in the company's interim Q2 management's discussion and analysis (MD&A), available under its profile on SEDAR+, the following should be noted:

1. In connection with its U.S. operations, the company distinguishes between in-network and out-of-network patients when determining reimbursement eligibility for patient visits conducted through its platform. For in-network patients, both the patient and the treating physician must be enrolled with the applicable insurance provider, Medicare or Medicaid, for a reimbursement claim to be eligible for payment. For out-of-network patients, the company has made a strategic decision to permit access to its platform to drive adoption and expand its user base during this early stage of its U.S. market development.
2. While reimbursement for out-of-network visits is generally not expected, the company will nonetheless submit claims on behalf of these visits where possible, as there remains a possibility that certain claims may be approved at the discretion of the payor.
3. Consistent with the company's overall revenue recognition policy for its U.S. operations, any amounts recovered in respect of out-of-network claims will only be recognized as revenue upon actual cash receipt, reflecting the heightened uncertainty of collection associated with these visits. Management will continue to evaluate its network coverage and payor relationships with a view to converting out-of-network patients and physicians to in-network status over time, which is expected to improve reimbursement rates and provide greater revenue visibility going forward.

About Rocket Doctor AI Inc.

Rocket Doctor AI delivers physician-built, AI-powered solutions designed to make high-quality health care accessible throughout the entire patient journey. A cornerstone of the company's proprietary technology is the Global Library of Medicine (GLM), a clinically validated decision support system developed with input from hundreds of physicians worldwide.

Alongside the GLM is Rocket Doctor Inc. and its AI-powered digital health platform and marketplace. Having helped empower over 350 MDs (medical doctors) to provide care to more than 800,000 patient visits, the company's proprietary technology software and systems enable doctors to independently launch and manage their own virtual or hybrid in-person practices -- improving efficiency, restoring autonomy to MDs and expanding patient access to care.

By reducing administrative burdens and ensuring greater consistency in care, the company's technology creates more time for meaningful physician-patient interactions. The company is committed to reaching underserved, rural and remote communities in Canada who often lack access to family doctors and supporting patients on Medicaid and Medicare in the United States. With advanced AI, large language models and connected medical devices, Rocket Doctor AI is redefining modern health care -- making it more scalable, equitable and patient centred.

We seek Safe Harbor.